Efficient molecular subtype classification of high-grade serous ovarian cancer-Reference-Cited by-同舟云学术

Efficient molecular subtype classification of high-grade serous ovarian cancer

Published:2015-04-30 Issue:3 Volume:236 Page:272-277
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Leong Huei San¹,Galletta Laura¹,Etemadmoghadam Dariush¹²³,George Joshy⁴,Köbel Martin⁵,Ramus Susan J⁶,Bowtell David¹²³⁷⁸,

Affiliation:

1. The Peter MacCallum Cancer Centre; East Melbourne Victoria Australia

2. Department of Pathology; University of Melbourne; Melbourne Victoria Australia

3. Sir Peter MacCallum Cancer Centre Department of Oncology; University of Melbourne; Melbourne Victoria Australia

4. The Jackson Laboratory for Genomic Medicine; Farmington Connecticut USA

5. Department of Laboratory Medicine and Pathology; University of Calgary; Calgary Alberta Canada

6. Department of Preventive Medicine, Keck School of Medicine, USC/Norris Comprehensive Cancer Center; University of Southern California; Los Angeles California USA

7. The Department of Biochemistry; University of Melbourne; Parkville Victoria Australia

8. Hammersmith Hospital, Imperial College; London UK

Funder

U.S. Department of Defense

Medical Research and Materiel Command, U.S. Army Medical Department

National Health and Medical Research Council

Cancer Council Victoria

Cancer Council South Australia

Peter MacCallum Cancer Foundation

Cancer Council New South Wales

Cancer Council Tasmania

Cancer Foundation of Western Australia

Ovarian Cancer Australia

Queensland Cancer Fund

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference24 articles.

1. Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry;Kobel;Histopathology,2014

2. Risk factors for epithelial ovarian cancer by histologic subtype;Gates;Am J Epidemiol,2010

3. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24;Goode;Nature Genet,2010

4. ARID1A mutations in endometriosis-associated ovarian carcinomas;Wiegand;N Engl J Med,2010

5. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy;Sugiyama;Cancer,2000

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine Learning-Enhanced Extraction of Biomarkers for High-Grade Serous Ovarian Cancer from Proteomics Data;Scientific Data;2024-06-25

2. An Aptamer‐Based Nanoflow Cytometry Method for the Molecular Detection and Classification of Ovarian Cancers through Profiling of Tumor Markers on Small Extracellular Vesicles;Angewandte Chemie International Edition;2023-12-18

3. An Aptamer‐Based Nanoflow Cytometry Method for the Molecular Detection and Classification of Ovarian Cancers through Profiling of Tumor Markers on Small Extracellular Vesicles;Angewandte Chemie;2023-12-18

4. UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer;Journal of Experimental & Clinical Cancer Research;2023-10-19

5. Interferon-ε is a tumour suppressor and restricts ovarian cancer;Nature;2023-08-16